Literature DB >> 21445668

Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Helene Siilin1, Ewa Lundgren, Hans Mallmin, Dan Mellström, Claes Ohlsson, Magnus Karlsson, Eric Orwoll, Osten Ljunggren.   

Abstract

BACKGROUND: Age and sex are of importance in the development of primary hyperparathyroidism (PHPT), and the disease is most common in postmenopausal women. Skeletal complications are well known at an advanced stage of PHPT, although the impact on bone mineral density (BMD) is evident in patients with mild disease. This study examines the prevalence of PHPT in elderly men and its impact on BMD.
METHODS: Calcium homeostasis and BMD, measured by dual X-ray absorptiometry, were evaluated in 3014 men ages 69 to 81 years in the MrOS-Sweden cohort. Individuals with a low glomerular filtration rate (<21 ml/min/1.73 m2) and vitamin D deficiency (<50 nmol/l) were excluded. Among the remaining subjects, PHPT was assumed in subjects with above-normal albumin-adjusted serum (s)-calcium and plasma intact parathyroid hormone (p-iPTH) levels (PHPT group). BMD was compared between the PHPT group and men without PHPT. Subjects with inappropriately elevated iPTH (IEP group), based on both s-calcium (2.34 mmol/l) and iPTH (4.24 pmol/l) levels being above the median level, were compared to the rest of the cohort.
RESULTS: The prevalence of PHPT was estimated to be 0.73%. The mean BMD in the total hip and femoral neck was lower in the PHPT group than in the PHPT controls. Significantly lower BMD (p<0.05) was seen in the IEP group (total hip and lumbar spine).
CONCLUSIONS: Elderly men appear to have a lower prevalence of PHPT than women at the same age. The impact of disturbed calcium homeostasis on BMD was also evident in this population group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445668     DOI: 10.1007/s00268-011-1062-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

1.  Longitudinal studies of mild primary hyperparathyroidism.

Authors:  S Ljunghall; S Jakobsson; C Joborn; M Palmér; J Rastad; G Akerström
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

2.  Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention.

Authors:  A M Parfitt; D S Rao; M Kleerekoper
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

Review 3.  Effects of aging and drugs on normal renal function.

Authors:  J P Lash; C Gardner
Journal:  Coron Artery Dis       Date:  1997 Aug-Sep       Impact factor: 1.439

Review 4.  Changes in renal function with aging.

Authors:  L H Beck
Journal:  Clin Geriatr Med       Date:  1998-05       Impact factor: 3.076

5.  Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments.

Authors:  S L Hui; S Gao; X H Zhou; C C Johnston; Y Lu; C C Glüer; S Grampp; H Genant
Journal:  J Bone Miner Res       Date:  1997-09       Impact factor: 6.741

6.  Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.

Authors:  Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

7.  Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus.

Authors:  Christine Chappard; Christian Roux; Pascal Laugier; Michel Paillard; Pascal Houillier
Journal:  Joint Bone Spine       Date:  2005-04-16       Impact factor: 4.929

Review 8.  Vitamin D deficiency and primary hyperparathyroidism.

Authors:  Shonni J Silverberg
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

Review 9.  Parathyroid hormone signaling in bone and kidney.

Authors:  Minnkyong Lee; Nicola C Partridge
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-07       Impact factor: 2.894

10.  Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity.

Authors:  Helene Siilin; Jonas Rastad; Osten Ljunggren; Ewa Lundgren
Journal:  J Clin Endocrinol Metab       Date:  2007-11-27       Impact factor: 5.958

View more
  5 in total

1.  The natural history and hip geometric changes of primary hyperparathyroidism without parathyroid surgery.

Authors:  Kyong Yeun Jung; A Ram Hong; Dong Hwa Lee; Jung Hee Kim; Kyoung Min Kim; Chan Soo Shin; Seong Yeon Kim; Sang Wan Kim
Journal:  J Bone Miner Metab       Date:  2016-04-02       Impact factor: 2.626

2.  Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.

Authors:  Gaëtan-Romain Joliat; Nicolas Demartines; Luc Portmann; Ariane Boubaker; Maurice Matter
Journal:  Langenbecks Arch Surg       Date:  2015-11-21       Impact factor: 3.445

3.  The DNA methylome of benign and malignant parathyroid tumors.

Authors:  Lee F Starker; Jessica Svedlund; Robert Udelsman; Henning Dralle; Göran Akerström; Gunnar Westin; Richard P Lifton; Peyman Björklund; Tobias Carling
Journal:  Genes Chromosomes Cancer       Date:  2011-06-02       Impact factor: 5.006

4.  The association between Single Nucleotide Polymorphisms of Klotho Gene and Mortality in Elderly Men: The MrOS Sweden Study.

Authors:  Ping-Hsun Wu; Per-Anton Westerberg; Andreas Kindmark; Åsa Tivesten; Magnus K Karlsson; Dan Mellström; Claes Ohlsson; Bengt Fellström; Torbjörn Linde; Östen Ljunggren
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

5.  Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors.

Authors:  Qing Li; Yonghao Li; Ximei Sun; Xinlei Zhang; Mei Zhang
Journal:  Int J Endocrinol       Date:  2022-07-16       Impact factor: 2.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.